Medicare Enrolled

Dr. Arun Rao, M.D.

Medical Oncology · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3327 RESEARCH PLZ STE 102, San Antonio, TX 78235
2103374494
In practice since 2006 (19 years)
NPI: 1174547590 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rao? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rao

Dr. Arun Rao is a medical oncology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rao performed 27,798 Medicare services across 1,546 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rao received a total of $5,368 from 56 pharmaceutical and/or device companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rao is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 31% volume in TX $5,368 industry payments

Medicare Practice Summary

Medicare Utilization ↗
27,798
Medicare services
Top 31% in TX for medical oncology
1,546
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,463 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron sucrose injection (Venofer) 11,500 $0 $2
Anti-nausea injection (fosaprepitant) 9,300 $0 $5
Epoetin alfa injection (Retacrit) for anemia 1,116 $6 $28
Dexamethasone injection (steroid) 880 $0 $1
Anti-nausea injection (Aloxi/palonosetron) 680 $1 $114
Complete blood count (CBC) with differential 663 $8 $36
Blood draw (venipuncture) 572 $8 $20
Comprehensive metabolic blood panel 512 $10 $64
Office visit, established patient (20-29 min) 406 $62 $250
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 237 $22 $157
Drug injection, under skin or into muscle 192 $10 $96
Office visit, established patient (30-39 min) 183 $94 $368
Ferritin level test (iron stores) 155 $13 $60
Iron level test 153 $6 $27
Iron binding capacity test 153 $9 $35
Administration of chemotherapy into vein, 1 hour or less 119 $101 $707
Immunoglobulin level test 109 $9 $56
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 102 $47 $313
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 94 $20 $128
Lactate dehydrogenase (enzyme) level 81 $6 $31
Measurement of immunoglobulin light chains 74 $17 $60
Administration of additional new drug or substance into vein, 1 hour or less 70 $50 $344
Infusion, normal saline solution , 1000 cc 68 $2 $19
Carcinoembryonic antigen (cea) protein level 61 $19 $99
Irrigation of implanted venous access drug delivery device 53 $20 $114
Injection, diphenhydramine hcl, up to 50 mg 51 $1 $7
Administration of additional new drug or substance into vein using push technique 42 $43 $289
Administration of chemotherapy into vein, each additional hour 36 $22 $161
New patient office visit, complex (60-74 min) 27 $159 $709
Red blood count automated, with additional calculations 25 $5 $26
Beta-2 microglobulin (protein) level 20 $16 $96
Vitamin B-12 level test 19 $15 $76
Folic acid level test 19 $14 $73
Initial hospital admission, moderate complexity 13 $102 $470
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 13 $90 $657
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
85.9% medium
12.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,368
Total received (2018-2024)
Avg $767/year across 7 years
Top 47% in TX for medical oncology
56
Companies
305
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,956 (92.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$412 (7.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$646
2023
$203
2022
$156
2021
$1,393
2020
$1,166
2019
$1,044
2018
$759

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$725
PFIZER INC.
$518
AstraZeneca Pharmaceuticals LP
$419
E.R. Squibb & Sons, L.L.C.
$311
Merck Sharp & Dohme Corporation
$271
Daiichi Sankyo Inc.
$250
Lilly USA, LLC
$248
Genentech USA, Inc.
$178
Janssen Biotech, Inc.
$163
Novartis Pharmaceuticals Corporation
$148
Celgene Corporation
$111
Myriad Genetic Laboratories, Inc.
$110
GENZYME CORPORATION
$105
Merck Sharp & Dohme LLC
$96
Astellas Pharma US Inc
$95
Eisai Inc.
$88
Seagen Inc.
$88
Teva Pharmaceuticals USA, Inc.
$88
EMD Serono, Inc.
$88
BeiGene USA, Inc.
$80
Rigel Pharmaceuticals, Inc.
$72
Janssen Pharmaceuticals, Inc
$69
Bayer Healthcare Pharmaceuticals Inc.
$69
EISAI INC.
$57
AbbVie, Inc.
$54
GlaxoSmithKline, LLC.
$50
AbbVie Inc.
$49
Puma Biotechnology, Inc.
$49
Bayer HealthCare Pharmaceuticals Inc.
$47
ARRAY BIOPHARMA INC
$46
Takeda Pharmaceuticals U.S.A., Inc.
$43
Taiho Oncology, Inc.
$42
Dendreon Pharmaceuticals LLC
$41
MEDIVATION FIELD SOLUTIONS LLC
$40
TerSera Therapeutics LLC
$38
Pharmacyclics LLC, An AbbVie Company
$36
Regeneron Healthcare Solutions, Inc.
$33
SOBI, INC
$32
Otsuka America Pharmaceutical, Inc.
$29
Verastem, Inc.
$27
Exelixis Inc.
$25
Agios Pharmaceuticals, Inc.
$25
Pharmacyclics LLC, an AbbVie Company
$24
Seattle Genetics, Inc.
$23
JAZZ PHARMACEUTICALS INC.
$20
Ipsen Biopharmaceuticals, Inc
$17
Adaptive Biotechnologies Corporation
$16
Aurobindo Pharma USA, Inc.
$15
Incyte Corporation
$14
AMAG Pharmaceuticals, Inc.
$13
Foundation Medicine, Inc.
$13
ABBVIE INC.
$12
Servier Pharmaceuticals LLC
$12
Gilead Sciences, Inc.
$12
Coherus Biosciences Inc.
$12
Secura Bio, Inc.
$10
Top 3 companies account for 31.0% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Alecensa · Avastin · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · EMPLICITI · ERLEADA · Enhertu · Erleada · FERAHEME · FOUNDATIONONE · Fabhalta · Farydak · GAZYVA · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MYRISK · Marqibo · Nerlynx · Neulasta · Nexavar · Nplate · OJJAARA · OPDIVO · OPDUALAG · PADCEV · PROMACTA · PROVENGE · Perjeta · Pomalyst · Prolia · REBLOZYL · RETEVMO · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Udenyca · VENCLEXTA · VERZENIO · Vanflyta · Vectibix · Venclexta · Vitrakvi · XARELTO · XTANDI · Xospata · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $19 per 100 Medicare services performed
Looking for a medical oncology specialist in San Antonio?
Compare medical oncologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
37
Per 100K population
1.8
County median income
$70,571
Nearest hospital
SAN ANTONIO STATE HOSP STATE SCHOOL
3.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rao is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rao experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Rao performed 11,500 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rao receive payments from pharmaceutical companies?
Yes. Dr. Rao received a total of $5,368 from 56 companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rao's costs compare to other medical oncologists in San Antonio?
Dr. Rao's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →